RACHEL MCBRIDE: Open Payments
NPI 1699219436 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 8 companies in 2025. Trend: 2023 $252 · 2024 $256 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $68 |
| Impulse Dynamics (USA) Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
| VivaQuant Inc, dba Rhythm Express | 1 | $9 |
Products named: VERQUVO, Optimizer, CARDIOMEMS, AREXVY, Ozempic, NEXLETOL, MOUNJARO, RHYTHM EXPRESS.
Industry payments across OK — which companies pay providers there.
